Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
177 participants
OBSERVATIONAL
2019-09-04
2020-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CI users
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults must wear a MED-EL cochlear implant
* Adults may have the following hearing indications and device fitting:
* Unilateral cochlear implant with severe-to-profound hearing loss
* Bilateral cochlear implant with severe-to-profound hearing loss
* Single sided deafness (SSD) where the poorer ear PTA ≥70 dB HL and the better ear PTA ≤30 dB HL with an interaural threshold gap of ≥40 dB HL.
* Asymmetrical hearing loss using a cochlear implant in the poorer ear and a hearing aid in the better ear (also known as bimodal fitting). The poorer ear PTA ≥70 dB HL and the better ear PTA \>30 dB HL and ≤55 dB HL with an interaural threshold gap of ≥15 dB HL.
* Adults should have a minimum of one year's device experience
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Hearing Centre
UNKNOWN
Hospital Universitario La Paz
OTHER
Fiona Stanley Hospital
OTHER
Wuerzburg University Hospital
OTHER
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Griet Mertens
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital La Paz
Madrid, , Spain
Fiona Stanley Fremantle Hospital Group
Perth, , Australia
University Hospital Antwerp
Edegem, , Belgium
University Clinic of Würzburg
Würzburg, , Germany
World Hearing Centre
Kajetany, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20/23/300
Identifier Type: -
Identifier Source: org_study_id